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SUMMARY : Radiation has been applied widely to clinics, researches and industries 
nowadays. Irradiation by atomic bomb produced many victims in Hiroshima and 
Nagasaki. Radiation effects on animals and human belings have been reported extensively, 
especially at a dose range of high amount of radiation. As radiation effects at low dose 
have not been well studied, it is believed that even a small amount of radiation produces 
hazardous effects. However, it might not be true. Beneficial effects of a low dose of 
radiation are summarized here.
       INTRODUCTION 
 Radiation is a useful too in clinics, researches 
and industries. However, it is hazardous when 
its large amount is exposed to human beings. 
It has been thought that even a small amount 
of radiation produces damages in proportion to 
its amount. However, we don't know how a low 
dose of radiaton affects human beings. The 
beneficial effects of low dose radiation on mam-
mals are summarized here.
      IMMUNE RESPONSE 
 The immune suppressive effects of radia-
tion have been known when a large amount of 
radiation is exposed. However, radiation acts 
as immune augmentation when a small dose of 
radiation is exposed" 3'. In vitro response of 
spleen cells to sheep red blood cells after ex-
posure to radiation is shown in Fig. 1." The 
number of plaque-forming cells is indicated as
a percentage of the control against radiation 
dose. Low doses of radiation, 0.25 to 0.5 Gy, 
showed augmented response. Above 0.75 Gy, 
the response was reduced less than control. 
This augmentation might be due to injury of 
highly radiosensitive suppressor T cells or 
their subpopulation. It can be said that the low 
dose of radiation results in an enhancement of 
the immune mechanism leading to increased 
antibody formation. When radiation exposure 
is performed with a low dose rate for a extend-
ed period of time, it become clear whether cell 
delation and radiation damage are accumula-
tive, or whether homeostatic adaptation to 
radiation is generated. Radiation exposure to 
mice at a low dose rate was extended for a 
period of 25 days''. Proliferative response of 
spleen cells from irradiated mice was analyz-
ed by phytohemagglutinin stimulation. The in-
crease in 3H-thymidine uptake is shown in Fig. 
2. Radiation exposure with a dose to 0.8 Gy
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during a period of 20 days increased prolifera-
tive response of spleen cells. Stimulative effect
Fig. 1. In vitro response of spleen cells to sheep 
      red blood cells after exposure to radia-
       tion".
Fig. 3. Tumor growth after implantation of 104 
       cells". Solid curve : control, shaded bars : 
      injection of 104 mitomycin treated cells, open 
      bars : injection of 10' mitomycin treated cells 
      with whole body irradiation with a dose of 
      0.15 Gy.
Fig. 2. The increase in 3H-thymidine uptake to 
      spleen cells after the exposure to radiation 
      for a period of 20 days".
of radiation was seen in the short period ex-
posure as well as the long period exposure.
       TUMOR GROWTH 
 Irradiation with a low dose augments the 
immune function of animals and affects sup-
pression of the grpwth of transplanted tumors2'. 
A dose of 0.15 Gy was exposed to whole body 
of mice and 104 mitomycin-treated tumor cells 
were injected subcutaneously into mice. After 
21 days, mice received 104 viable tumor cells. 
The tumor size after the inoculation of the viable 
tumor cells is shown in Fig. 3. A solid curve 
with closed circles is of control. Shaded bars 
are of mitomycin-treated cells. Open bars are
Fig. 4. The fraction of irradiated mice failed to 
      develop tumors after inoculation of 104
       tumor cells 3).
of mitomycin-treated cells with whole body 
irradiation. ' With 0.15 Gy. By the injection of 
mitomycin-treated cells, the tumor growth was 
inhibited, and the irradiation suppressed the 
tumor growth further. These effects might be 
caused by the immune augmentation. 
 The low dose irradiation suppressed the 
transplantability of tumors'). Radiation was 
exposed to mice just before the inoculation of 
104 tumor cells. The exposure with low doses, 
from 0.1 Gy to 0.3 Gy, resulted that 20 % to 30 %
Fig. 5. Tumor dose 50, TD50, of mice irradiated with a dose of 0.1 Gy"'
of mice failed to develop tumors as seen in Fig. 
4. This low dose augmentation is less pro-
nounced in animals that have undergone sple-
nectomy. Very radiosensitive suppressor T cells 
might be implicated in this phenomenon. 
 The tumor transplantability was assayed by 
tumor dose 50 %, or TD50, which indicates the 
number of tumor cells forming a tumor in 
transplanted mice in 50 %1". The larger TD50 
means the more difficulty of tumor formation. 
Irradiation with a dose of 0.1 Gy increased TD5o 
value than nonirradiated control (Fig. 5). This 
means that a low dose suppressed the trans-
plantability of tumor cells in mice. The result 
is associated with the suppression of the tumor 
transplantation which is shown in the above 
study. 
 It was examined whether the low doe affected 
radiosensitivity or tumor cells growing in mice" 
104 tumor cells were transplanted into mice, 
and after 12 days of the transplantation, a dose 
of 0.1 Gy was exposed to the whole body of the 
tumor bearing mice. The radiosensitivity after 
12 hours of irradiation is show in Fig. 6. Solid 
curve with solid circles in figure is of control, 
nonirradiation. The curve has a steep decreas-
ing part of the surviving fraction at a low dose 
region, and a tail part at a high dose region. 
The steep part corresponds to the surviving 
fraction of aerobic cells in tumors, and the tail 
part dose to that of hypoxic cells. A dotted curve 
with open circles is of tumor bearing mice 
irradiated with the dose of 0.1 Gy. The initial
Fig. 6. Radio sensitivity of tumor cells in mice after 
      the whole body irradiation with a dose of 
       0.1 Gy'"
decreasing part was the same of the control. 
However, the tailing part of the surviving fac-
tion was lower than the control. This means 
irradiation changed immune function resulting
Fig. 7. The incorporation of 3H-thymidine into spleen cells isolated from 
       tumor bearing mice by the stimulation by mitogens"'. Con-A: 
      concanavalin-A, PHA : phytohemagglutinin, IL-2: interleukin 2, 
      MLR : mixed lymphoid reaction
in as if the decrease in the fraction of hypoxic 
cells. 
 Irradiation with the dose of 0.1 Gy changed 
immune response assayed by the stimulation 
by mitogens"'. Fig. 7 shows the incorporation 
of 3H-thymidine into spleen cells isolated from 
tumor bearing mice in the stimulation by 
concanavalin-A (Con-A), phytohemagglutinin 
(PHA), interleukin 2 (IL-2) and mixed lymphoid 
reaction (MLR). The percentage of the incor-
poration into spleen cells from nontumor bear-
ing mice was indicated. Shaded bars are of 
tumor bearing mice without irradiation, and 
open bars are of tumor bearing mice for 0.1 Gy 
whole body irradiation. In any stimulation, 
irradiation with the dose 0.1 Gy augumented 
immune response.
Table 1. Mean Survival time of LAF, mic' 
 Sex Control Irradiated Difference 
             days days days 
Male 684 ± 14 783 ± 14 99 
Female 803 ± 16 820 ± 18 17
       SURVIVAL TIME 
 Mice were irradiated with a low dose rate, 0.14 
mGy per hour, every days for 8 hours a day until 
mice die'. And the mean survival time was 
examined (Table 1). For male mice, the mean 
survival time was 684 days for control and 783 
days for irradiated mice. The mean survival 
time was increased by 99 days by irradiation. 
However, for female mice, the mean survial time 
was 803 days for control and 820 days for 
irradiated mice, the difference was 17 days. This
difference was not significant statistically. Male 
mice would be affected by the environmental 
conditions such as irradiation, although female 
mice would not.
  CHROMOSOME ABERRATION 
 Chromosome aberration of human lympho-
cytes was produced by the exposure with a dose 
of 1.5 Gy. The exposure with a low dose of 0.01 
Gy before 1.5 Gy irradiation decreased the 
chromosome aberration 12'. Fig. 8 shows the 
decrease of chromosome aberration with the 
interval between two doses, 0.01 Gy and 1.5 Gy. 
This decrease in the chromosome aberration 
might be adaptive response to irradiation. A 
low dose might change the structure of chro-
mosome, and this change suppreassed the chro-
mosome aberration induced by successive ir-
radiation.
Fig. 8. The decrease of the chromosome aberration 
      irradiation with a low dose"'. The time 
      interval between a dose of 0.01 Gy and a 
      test dose of 1.5 Gy is indicated on abscissa.
      A-BOMB SURVIVORS 
 Cellular immune functions were analyzed 
among victims who survived the atomic bomb 
in Hiroshima and who lived in the United States 
of Americas' Radiation doses of the exposed 
group were from 0.01 Gy to 0.5 Gy. Lymphocytes 
were isolated from the peripheral blood of those 
individuals, and natural cell-mediated cyto-
toxicity (NCMC) was assessed and the results 
are shown in Fig. 9. The difference of cy-
totoxicity was significant statistiaclly. Other 
immune function was analysed by mitogen 
responsr to phytohemagglutinin and to allo-
geneic lymphocytes and interferon production. 
Although the same trend of the increase was 
observed, the differences were not significant 
statistically. The same study has been per-
formed on the atomic bomb survivors living in 
Hiroshima". But the study did not confirm this 
difference. The different environmental con-
ditions between the United States and Japan
Fig. 9. Natural cell-mediated cytotoxicity of A-bomb 
        survivors".
might have affected the immune function. 
 The rate of death from leukemia in atomic 
bomb survivors in Nagasaki and Hiroshima 
is shown in Fig. 107'. A solid curve is for 
Hiroshima, and a dotted curve is for Nagasaki. 
The death rate increases with dose for both 
cities, although the rate for Hiroshima was 
higher than that for Nagasaki. From this figure 
it is clear that there is a threshold dose before 
the rate increases with dose. Above the 
threshold dose, the increase in death rate is 
observed. Below the threahold the rate is nearly 
the same or smaller than control. 
 It is widely belived that cancer death is 
observed even at a low dose range in propor-
tion to radiation dose. Howere, the threshold 
dose of cancer mortality analyzed for the atomic 
bomb surviors is observed as shown in Table 
2. The threshold dose was observed in many 
cancer deaths. From the table, we can under-
stand that thre is no increase in the inci-
dence of cancer death by irradiation under the 
threshold dose in some cancer.
Table 2. Threshold of Cancer Mortality" 
 Cancer Nagasaki Hiroshima 
                Gy Gy 
Leukemia 0.36 0.12 
 Lung 0.28 ND 
 Breast 0.08 ND 
 Colon 0.54 0.31 
Stomach ND 0.12 
                              NT)- Nnt detected
Fig. 10. The Rate of death of leukemia in A-bomb 
       survivors in Nagasaki and Hiroshima".
 The risk of death, or the ratio of death rate 
to that of control, for male survivors is shown 
in Fig. 1110). For total death, the risk was about 
unity for the dose range examined. The risk 
of cancer increased with dose. We confirmed 
that the irradiation causes cancer. However, the 
risk of noncancer disease decreased to 0.65 
around 1 Gy of radiation dose, and this decrase 
was significant statistically. Radiation from 
atomic bombing decreased the mortality from 
noncancer disease at a low dose range. This 
beneficial effect of low dose radiation is called 
radiation hormesis. 
 In conclusion, it can be said that animal and 
human beings have systems to respond to the 
low dose radiation. One of main response is 
of immune system. And the stimulation by the 
low dose radiation resulted in the low martality
Fig. 11. The risk of death for male A-bomb survivors : total death, cancer 
         and non-cancer diseases'°
from noncancer disease for male survivors. The 
low dose of radiation is not necessarily harmful, 
but rather beneficial under certain conditions.
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